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ABSTRACT An investigation of gelatinase A binding to gelatin produced results that are inconsistent with a traditional
bimolecular Michaelis-Menten formalism but are effectively accounted for by a power law characteristic of fractal kinetics. The
main reason for this inconsistency is that the bulk of the gelatinase A binding depends on its ability to diffuse laterally on the
gelatin surface. Most interestingly, we show that the anomalous lateral diffusion and, consequently, the binding to gelatin is
greatly facilitated by the C-terminal hemopexin-like domain of the enzyme whereas the specificity of binding resides with the
fibronectin-like gelatin-binding domain.
INTRODUCTION
The three-dimensional scaffold of vertebrate extracellular
matrix (ECM) consists of highly organized, insoluble as-
semblies of large protein molecules, including collagens,
proteoglycans, fibronectin, laminin, etc., giving tensile
strength to the tissue (Kreis and Vale, 1999; Yurchenko et
al., 1994). Morphogenesis (Damsky et al., 1997; Werb and
Chin, 1998), tissue repair (Chiquet, 1999; Trojanowska et
al., 1998), angiogenesis (Friedl and Brocker, 2000; Norrby,
1997), uterine involution, and bone resorption (Karsenty,
1999) are characterized by intensified tissue remodeling that
begins with degradation of the existing ECM. Resident cells
of tissues can secrete a specialized group of enzymes, ma-
trix metalloproteases (MMPs) (Massova et al., 1998), that
can degrade ECM macromolecules such as collagens and
proteoglycans (Vu and Werb, 2000). Malignant cells can
exploit these same proteases to promote tumor invasion and
metastasis (Kleiner and Stetler-Stevenson, 1999; Wood-
house et al., 1997). Gelatinases A (GelA) (Collier et al.,
1988) and B (GelB) (Wilhelm et al., 1989) are closely
related enzymes of this family that, in addition to their
catalytic and hemopexin-like carboxyl-end domains, con-
tain a distinct domain composed of three head-to-tail repeats
homologous to the type 2 repeat found in fibronectin (FN).
The FN domain confers gelatin substrate binding properties
to these proenzymes (Collier et al., 1992). The hemopexin-
like, carboxyl-terminal domain (GelA-CTD) plays an im-
portant role in membrane activation of the enzyme (Brooks
et al., 1996; Butler et al., 1998; Deryugina et al., 2000,
1998; Kinoshita et al., 1998; Kolkenbrock et al., 1997;
Quigley and Cheresh, 1996; Strongin et al., 1995) and
binding of the inhibitors TIMP and TIMP2 (Goldberg et al.,
1989, 1992; Fridman et al., 1992; Olson et al., 1997). Its
role in substrate recognition, however, remains unclear
(Knauper et al., 1997; Murphy and Knauper, 1997; Wilhelm
et al., 1987).
MMP-substrate interactions have been studied applying
the Michaelis-Menten formalism based on traditional mass-
action kinetics. However, when reactions are restricted to
two or fewer dimensional spaces, as can exist in the ECM in
vivo, fractal kinetics (Avnir, 1989; Havlin, 1989; Kopel-
man, 1988) provides a better description of bimolecular
reactions. Here we present a serial model for GelA substrate
recognition and show the binding to be dependent on anom-
alous diffusion of the enzyme on the gelatin surface.
MATERIALS AND METHODS
Enzyme purification and labeling
Cells were grown in RPMI 1640 supplemented with 2 mM glutamine and
5% fetal calf serum. GelA proenzyme was purified from conditioned
medium of p2aHT7211A cells (Strongin et al., 1993). The truncated mutant
of GelA (GelA-Tr) lacking the hemopexin-like carboxyl-end domain was
prepared from conditioned medium of p2AHT2a (Frisch et al., 1990)
transiently transfected with expression plasmid psg5 bearing an insert
coding for GelA Met1-Leu 461. The predicted molecular mass of the
GelA-Tr, 48,229 Da, was in good agreement with that determined by
SDS/PAGE.
All binding experiments were performed with biosynthetically labeled
enzyme to assure the integrity of the protein that might be compromised
upon labeling in vitro. For biosynthetic labeling of proteins, cells were
transferred into Met-deficient medium containing 50 Ci/ml of trans[35S]
label (ICN Radiochemicals, Costa Mesa, CA, 1000Ci/mM) 12 h before
harvesting the secreted enzyme.
For fluorescence photobleaching recovery (FPR) experiments, purified
enzymes were tagged with fluorescent dye Alexa Fluor 488. To prevent
interference of the dye with the gelatin-binding site the reaction was
performed on the enzyme bound to gelatin as described below. The purified
GelA and truncated mutant were labeled with the Alexa Fluor 488 protein
labeling kit (Molecular Probes, Eugene, OR), and 100 g of either protein
was adsorbed onto a 100-l bed volume column of gelatin agarose (Sigma
G-5384, Sigma Chemical Co., St. Louis, MO) equilibrated with 25 mM
HEPES buffer, pH 7.5, containing 150 mM NaCl and 2 mM CaCl2 at 4°C.
A 250-l volume of Alexa 488 dye (50% of the vial content) dissolved in
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column buffer was added to a dry column and incubated in the dark for 45
min at room temperature with agitation. Columns were washed with the
same buffer and eluted with buffer containing 10% dimethylsulfoxide.
Proteins were dialyzed into 25 mM HEPES buffer, pH 7.5, containing
0.005% Brij 35. This protocol yielded the fluorescent enzyme labeled with
1 mol of dye per mol of enzyme on average. Both biosynthetically labeled
and Alexa Fluor-488-tagged enzymes were stable at room temperature for
the duration of the experiments.
Binding measurement and analysis
Enzyme binding was measured at room temperature. Polystyrene Flash-
plates plates (New England Nuclear, Boston, MA) were used according to
manufacturer’s instructions to determine binding of 35S biosynthetically
labeled enzymes. The wells of the Flashplates plates were coated with 100
l of gelatin (Biorad, Richmond, CA; 2 g/ml) in 10 mM Tris-HCl buffer,
pH 7.5. Control wells were coated with 100 l of bovine serum albumin
(BSA; 1 mg/ml) in the same buffer. After 1 h, wells were rinsed and
incubated overnight at 4°C with 100 l of 25 mM HEPES buffer, pH 7.5,
containing 1 mg/ml BSA, 150 mM NaCl, and 0.005% Brij-35 (BB, binding
buffer). All binding measurements were performed in the BB buffer
containing 1  105 M metalloprotease inhibitor SC67787 (BBI buffer).
To measure binding in real time, solutions containing radiolabeled ligands
in BBI buffer were added simultaneously to the gelatin-coated and control
wells, which were counted simultaneously at the indicated times using a
Packard TopCount scintillation counter. The specific ligand binding was
the difference in cpm of the gelatin- and the BSA-coated wells divided by
the molar specific activity of the ligand in units of cpm mol1. An
arbitrary unit of micromoles per well (mol well1) is introduced for
convenience to express the surface concentration of ligand bound. Where
necessary, it is converted to absolute units using a value of 0.55  0.1 cm2
for the absorbing area of the well.
For measurements of ligand binding where time was not an independent
variable, the plates were incubated for 90 min and the solution containing
the ligand removed by blotting the inverted plate before counting as above.
The bimolecular reaction scheme for binding of a ligand in solution to
gelatin is:
XM ¢O¡
kf
kd
MX,
where X stands for the ligand, M for gelatin, and MX for their complex. If
the ligand solution concentration, x0, is constant, then conventional kinet-
ics yields the well known expressions for the amount of complex, mx,
formed with respect to time, t:
mx mxmx0 1 expkat, (1.1)
where
mxmx0 m0 x0 kf 	kd x0 kf
1
 b m0 x0/	1 b x0
 (1.2)
The equilibrium binding constant is
b kf /kd. (1.3)
The apparent time constant is
ka kf x0 kd b kd x0 kd. (1.4)
If a competing species is present with concentration i0, Eq. 1.2 becomes
mxmx0 b m0 x0/	1 bi i0 b x0
, (1.5)
where bi is the equilibrium binding constant of the competing ligand.
The serial reaction scheme for binding of a ligand to gelatin is:
where X stands for the ligand and I for its competitor. S1 through S3 stand
for gelatin sites associated with the first step in the binding reaction, and
S1X through S3X or S1I through S3I for their complexes with the ligand or
its competitor. M represents gelatin sites associated with the second step of
the binding reaction, and MX and MI represent their complexes with the
ligand or its competitor. In the first step of the binding reaction, a ligand or
competitor in solution binds at one of the S sites. In the second reaction, a
ligand or competitor bound to one of the S sites translocates to one of the
M sites that are inaccessible directly from solution. The rate constants for
competitor binding to the S sites are identical to those of the ligand itself,
whereas the rate constants for translocation of the competitor to the M sites
may be different from that of the ligand itself.
If the binding to precursor S sites by ligand or competitor is in equi-
librium, then the amount of ligand-S site complex of each kind is:
snx sn0 bn x0/	1 bn i0 bn x0
 (2.0a)
and
sni sn0 bn i0/	1 bn i0 bn x0
;
n 1, 2, 3, (2.0b)
where bn ksnf/ksnd, and the equilibrium binding constant of the ligand, bn,
and that of competitor species are identical according to the model as-
sumptions (see above). The sn0 are the total density of S sites of the of the
nth (n  1, 2, 3) class, and x0 and i0 are the constant solution concentra-
tions of the ligand and competitor species, respectively. Fractal-like kinet-
ics (Kopelman, 1988) yields the following rate equation for the irreversible
formation of the MX or MI complexes from the SNX or SNI complexes:
d	mx
/dt 
n1
3
ksnm th snx 	m0 mx mi

(2.0c)
d	mi
/dt 
n1
3
kisnm th sni 	m0 mx mi
.
(2.0d)
Equations 2.0a and 2.0b are integrated give the expression:
mx
m0 sumx0
e(sumi0sumx0) m0 sumi0 sumx0sumi0 sumx0 
 e(sumi0sumx0) m0 sumx02sumi0 sumx0 
sumi0 sumx0
(2.1)
SnX IMO¡
ksnm
Sn IMXksnfm,ksnd
Sn X IM n 1, 2, 3
nksndksnfb
SnI XMO¡
kisnm
Sn XMI,
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for mx as a function x0, i0, and t, where:
sumx0 
n1
3
ksnm snx, (2.2a)
sumi0 
n1
3
kisnm sni, (2.2b)
and
  t(1h)/	1 h
. (2.3)
In the absence of inhibitor, the M site binding (Eq 2.1) is given by:
mx m0 	1 esumx0
. (2.4)
When
t(1h) m0 sumx0 	1 h
1 0.15,
then
mx t(1h) m0 sumx0 	1 h
1. (2.5)
FPR measurement and analysis
FPR measurements were performed as described (Petersen and Elson,
1986) at room temperature. One side of 1.2-cm-diameter glass cover-
slips was covered with 100 l of gelatin solution (2 g/ml in 10 mM
Tris-HCl buffer, pH 7.5) and incubated overnight in a closed humidified
chamber. The gelatin-coated coverslips were rinsed exhaustively with
BBI before 50 l of either fluorescently labeled (FL) GelA (1 M in
BBI) or GelA-Tr (3 M in BBI) were applied. The samples were
incubated for 1 h in the dark and the excess of ligand removed by
washing the coverslips with BBI buffer. The coated side of the coverslip
was placed on top of a glass slide with 2 l of BBI buffer, and the edge
of the coverslip was sealed before FPR measurements. For delayed
measurements, the coated side of the coverslip was floated on top of a
50-l drop of BBI buffer and incubated for 1 h before being prepared
for FPR measurement as above.
The analysis of FPR data has been described (Axelrod et al., 1976). The
following modifications accommodate continuous monitor beam photo-
bleaching. Let K be the bleach parameter; T, time of bleach; l, photochem-
ical quantum yield; D, diffusion coefficient; c0, initial uniform concentra-
tion of diffusing fluorophore; w, the beam radius at exp(2) of its central
intensity; and I0B and I0M, the central maxima of bleaching and monitor
beams. The partial differential equation,
	c	r, t
/	t D2 c	r, t
 c	r, t

I0Mexp2	r/w
2,
(3.0a)
and the initial condition,
c	r, 0
 c0, (3.0b)
describe the self-diffusion of an initially uniform distribution of mobile
fluorophores in the presence of continuous monitor beam photobleaching.
Equation 3a and the initial condition,
c	r, 0
 c0 exp
I0BT exp[2	r/w
2},
K 
I0BT, (3.0c)
describe the self-diffusion of a non-uniform distribution of bleached mo-
bile fluorophores in the presence of continuous monitor beam photobleach-
ing. Eq. 3.0a together with either 3.0b or 3.0c is integrated numerically
(Wolfram, 1999), subject to the forced boundary conditions,
	c	rB, t
/	r 0, rB 10w
	c	r0, t
/	r 0, r0 w	8000
1
to yield, respectively, the time-dependent concentration profile of fluoro-
phores before, cP(r, t), or after, cR(r, t), photobleaching. The fluorescence
in arbitrary units, a(t), at time t is obtained from:
a	t
 cP	r,t
exp2	r/w
2 2rdr 	1 
F	t
;
t time of bleach
a	t
 cR	r, t
exp2	r/w
2 2rdr 	1 
F	t
;
t time of bleach, (3.1)
where  is the fraction of fluorophores that are mobile and
F	t
 c0 w2 p 1 exp	
I0Mt
 	2lt
1
F	t
 c0 w2 p 1 exp
I0M	t TR

 2
	t TR
1; R I0B/I0M.
The relative fluorescence is defined as
r	t
 a	t
/a(), (3.2)
where a() is the fluorescence immediately before the bleach.
Experimental values for D and  were calculated iteratively from
fluorescence recovery data normalized in accordance with Eq. 3.2. The
parameter w has been previously determined for each objective lens as
described (Axelrod et al., 1976). Given estimated values of D and , 
I0M
and R were determined from the prebleach and immediate postbleach
portions of the recovery curves, respectively. Improved values of D and 
were then obtained by incrementally varying their value until a minimum
in the 2 statistic for the entire recovery curve was obtained. These
procedures were implemented using the Mathematica (Wolfram Research,
Champaign, IL) system. To fit anomalous diffusion recovery curves to the
data, the recovery time t at each data point was replaced with t1/ Then all
parameters were determined as described above.
RESULTS AND DISCUSSION
Interaction of gelatinase A with gelatin is
described by a sequential binding model with
fractal-like kinetics
We have shown that the FN domain enables binding of
GelA proenzyme to gelatin (Collier et al., 1992). Recombi-
nant GelA-CTD does not bind gelatin (Collier and Gold-
berg, unpublished data) and, accordingly, does not compete
the enzyme binding (see Fig. 2, open triangles) providing
further evidence that binding specificity resides in the FN
domain. The apparent equilibrium binding of 35S-labeled
GelA can be described (Fig. 1 B) by a single binding
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isotherm, Eq. 1.2 (see Materials and Methods), with an
apparent binding constant of 1.2 105 M1 and site density
of 5.2  106 mol well1. Surprisingly, the truncated
mutant of GelA (GelA-Tr) lacking the GelA-CTD has a
poor gelatin-binding capacity (Fig. 1), and a single isotherm
(Fig. 1 D) fits the data poorly. To explain these results we
first considered a model with heterogeneous binding sites. A
minimum of three independent binding sites having densi-
ties of 108, 1.9  107, and 5.2  106 mol well1 and
corresponding equilibrium constants of 2.5  107 M1,
2.0  103 M1, and 5.4  102 M1 were required to
approximate the GelA-Tr binding data (Fig. 1). A change in
affinity of the three sites to 1.9 108, 7.5  105, and 1.2 
105 M1 produced an adequate description of the wild-type
enzyme binding (Fig. 1) and competition experiments (Fig.
2). We found, however, that the GelA-Tr is able to compete
the binding of GelA much beyond what would be expected
from its poor binding ability (Fig. 2). Thus, conventional
binding models with either single or heterogeneous binding
sites failed to account for the binding and the competition
behavior of the GelA-Tr. To further understand the mech-
anism of GelA and GelA-Tr binding to gelatin we examined
the kinetics of dissociation (Fig. 3) and association (Fig. 4)
for both enzyme forms.
GelA desorption (Fig. 3) was independent of initial sur-
face concentration, which was varied from 5 108 to 6 
107 mol well1. A fit of a single-exponential decay to the
dissociation data (Fig. 3 C) yielded kd  7.5  1.7  104
min1, demonstrating that binding is practically irreversible
(Fig. 3 A) with a half-life of 15 h. GelA-Tr dissociation was
also independent of initial surface concentration, which
varied from 1.4  109 to 3  108 mol well1, but
exhibited a fast mode of decay in addition to a slow mode
identical to that of wild type (Fig. 3 B). GelA association
time courses (Fig. 4) fitted to an exponential association
curve, Eqs. 1.0–1.5, yielded apparent time constants, ka,
which were independent of ligand concentration with a
mean value of 0.081  0.014 min1. This result together
with the equilibrium binding constant of the dominant bind-
ing component (1.0  105 M1) and Eq. 1.4, suggest that
GelA binding should be significantly reversible with a kd of
0.08 min1. This value is two orders of magnitude greater
than the kd determined above, indicating that conventional
kinetic mechanisms of binding and dissociation are inade-
quate to describe this system.
A power-law time dependence characteristic of fractal
kinetics (Avnir, 1989; Dewey, 1997; Havlin, 1989; Kopel-
man, 1988) produces a closer fit to association data (Fig. 4)
and suggests the way to resolve the contradiction. Fractal
kinetics implies that the binding reaction slows and appears
complete because it is self-limiting rather than because it is
approaching equilibrium. Thus, rate constants are replaced
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FIGURE 1 The concentration dependence of GelA (E) and GelA-Tr ()
binding. A 50-l volume of either 35S-GelA or 35S-GelA-Tr in BBI buffer
was diluted to reach final concentrations as indicated and added to Flash-
plates (Du Pont NEN) that were incubated for 90 min and counted. The
amount of GelA- or GelA-Tr-specific binding to gelatin is plotted on
double logarithmic axes versus the concentration of the ligand. (A) Fit of
Eq 2.4 (t  90min) to the wild-type binding data. (B) Unweighted two-
parameter nonlinear least-squares fit of Eq. 1.2 to the wild-type binding
data. (C) Fit of the sum of Eq 2.0a (binding to S sites) and 2.4 (binding to
M sites) to the mutant (GelA-Tr) binding data subject to the constraint that
S and M sites contribute equally to the total. (D) Unweighted two-
parameter nonlinear least-squares fit of Eq. 1.2 to the mutant (GelA-Tr)
binding data.
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FIGURE 2 Competition of gelatin binding by in vivo labeled 35S-GelA
with unlabeled GelA (E), GelA-Tr (), and GelA-CTD (‚). A 50-l
volume of 35S-GelA (0.015 M and 3.34  109 cpm/L) containing unla-
beled GelA, GelA-Tr, or GelA-CTD at the indicated molarity was added to
Flashplates (Du Pont NEN) that were incubated for 90 min and counted.
The amount of GelA-specific binding to gelatin expressed as a fraction of
the binding in the absence of competing ligand is plotted versus the
molarity of the competing ligand. The error bars along the ordinate are the
differences in the duplicate samples. (A) Linear regression on the 35 S
GelA competition by the recombinant GelA-CTD data. (B) Predicted
competition of GelA for a one-step process, Eq. 1.5, by a competitor with
both having an identical equilibrium binding constant of 1.2  105 M1.
(C and D) Competition of GelA by GelA-Tr or GelA itself, respectively,
predicted by the two-step binding model, Eq. 2.1.
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with time-dependent rate coefficients, kth where k is a
constant and h is the fractal exponent (0  h  1), charac-
teristic of the particular reaction system. Fractal kinetics
applied to a two-step sequential binding mechanism ex-
plains the binding behavior of GelA and GelA-Tr. In this
model (see Materials and Methods), adsorption of both
GelA and GelA-Tr from solution occurs at heterogeneous
(minimum of three) sites, S, constituting 1% or less of total
binding. Subsequently, the S-site-bound GelA translocates
to a second tier of binding sites, M, comprising the remain-
der of gelatin binding. The GelA-Tr is deficient in translo-
cation and thus cannot occupy the M sites to the extent that
GelA can. Due to the bottleneck effect created by the
limited number of accessible S sites, GelA-Tr effectively
competes GelA binding despite occupying few M sites. The
application of fractal kinetics to the translocation step of this
binding model produced a quantitative description of bind-
ing data with a fractal constant h  0.75 in Eqs. 2.0–2.4.
This value of h allows fitting Eqs. 2.4 and 2.1 to the GelA
binding concentration dependence (Fig. 1 A) and the com-
petition data (Fig. 2 D). The irreversible S-to-M transloca-
tion approximates the slow GelA dissociation (Fig. 3 A),
and the power-law Eq. 2.5 accounts for the time course
binding data (Fig. 4, A–E).
A reduction of the translocation rate constant in Eq. 2.1 is
sufficient to describe the binding behavior of GelA-Tr.
Because little GelA-Tr translocates from S to M sites during
the time period of the measurement, the mutant binding
(Fig. 1 C) is the sum of binding to S sites, Eq. 2.0a, and M
sites, Eq. 2.4, each accounting for half of the total. In
consequence, the time course of GelA-Tr dissociation can
be represented as the sum of a single exponential describing
the reversible S-site desorption and a constant representing
irreversible M-site binding (Fig. 3 B). Furthermore, the
exponential decay has a kd on order of 0.1 min1. This value
agrees with the mutant association data (Fig. 1 C; Fig. 4 F)
when approximated as the sum of rapid S-site binding and
slower M-site binding.
The above model assumes prior equilibrium binding at
the reversible S sites for both GelA and GelA-Tr, making
translocation the rate-limiting step. Hence, the overall frac-
tal nature of GelA binding can be attributed to the translo-
cation reaction. We hypothesize that the S-to-M transloca-
tion involves diffusion of the enzyme on the gelatin surface.
The C-terminal domain of gelatinase A facilitates
substrate recognition by enabling lateral diffusion
on the gelatin surface
We used fluorescence photobleaching recovery (see Mate-
rials and Methods) to test the ability of fluorescently labeled
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FIGURE 3 Gelatin dissociation time courses of labeled 35S-GelA (E)
and GelA-Tr (). Association reactions for GelA and GelA-Tr were
performed as described in Fig. 4 for enzyme concentrations ranging from
0.06 M to 1.1 M and 0.005 M to 6 M, respectively. After 110 min
of association reaction, the unadsorbed enzymes were replaced with buffer
and the amount of radioactivity associated with the wells was determined
at the indicated times. The GelA or GelA-Tr dissociation data were
normalized to the initial surface concentration and combined. (A) GelA
dissociation predicted by the two-step binding model where 99% (M sites)
of the binding is irreversible and 1% (S sites) decays exponentially with a
time constant of 0.1 min1. (B) A similar dissociation curve for GelA-Tr
where the distribution between the S and M sites is 50/50. (C) Fit of a
single-exponential decay to the GelA dissociation data having a kd 7.5
1.7  104 min1.
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FIGURE 4 The association time course of GelA (E) and GelA-Tr bind-
ing (). A 50-l volume of either 35S-GelA or 35S-GelA-Tr in BBI buffer
was diluted to reach final concentrations as indicated and added simulta-
neously to the gelatin (200 ng/well) or BSA-coated wells of Flashplates
(Du Pont NEN). The radioactivity associated with the wells was monitored
in real time and the amount of specific binding was plotted versus the time
after the addition of the ligand on double logarithmic axes. The error bars
were calculated from the signal-to-noise ratio of the control (BSA) and
gelatin wells. (A–E, ——) Two-parameter nonlinear least-squares fits of
the GelA association data at each concentration (1.1, 0.65, 0.38, 0.22, and
0.06 M, respectively) to Eq. 2.5. (F) Gelatin association time course
predicted for the mutant (GelA-Tr) by the sequential model of binding It is
the sum of rapid exponential association to the S sites (50%) and a
fractal-like association to the M sites (50%), Eq. 2.4 with h  0.75 
0.015.
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GelA and GelA-Tr to diffuse laterally on a gelatin substrate.
The isolated recovery phase of the entire FPR experiment
(Fig. 5 a) is seen in Fig. 5 b where the signal has been
normalized to the value of fluorescence just before photo-
bleaching. The results clearly demonstrate that the recovery
of the GelA-Tr fluorescence is significantly reduced com-
pared with the wild-type enzyme (Fig. 5). Recovery curve
analysis (Axelrod et al., 1976) was modified (see Materials
and Methods) to account for significant monitor beam pho-
tobleaching apparent in the prebleach portion of the exper-
iment (Fig. 5 a). Curve A (Fig. 5 b) is the predicted diffu-
sion-dependent recovery curve for a diffusion coefficient of
0.4  109 cm2 s1 and a mobile fraction of 0.42 resulting
from a least-squares fit of Eq. 3.2 to the data. Such fitted
curves consistently underestimated the recovery in the first
20–25 s after photobleaching in all data sets. Likewise,
curves fit to the first 30 s of recovery using Eq. 3.2 consis-
tently underestimated the total recovery at 100–200 s, sug-
gesting that the recovery data had a long tail (results not
shown). Webb and co-workers (Feder et al., 1996) have
shown that long time tails in FPR may arise from anomalous
diffusion (Bouchaud and Georges, 1990) when recovery
becomes a function of t (1) rather than t as for Brownian
diffusion.
To test whether the GelA FPR is better described by an
anomalous diffusion, the data from four independent FPR
measurements were fit (Fig. 5 b, curve B) using Eq. 3.2,
modified to account for anomalous diffusion and compared
with the normal diffusion, Eq. 3.2, using the 2 statistic. The
observed differences favored the anomalous diffusion with
a 95% confidence level by Student’s t-test (compare Fig. 5,
curve A with curve B). The average anomalous transport
coefficient was 2.1  0.5  109 cm2 s1 with an average
mobile fraction of 0.33  0.03 when   0.66. A lower
signal-to-noise ratio combined with significantly reduced
recovery in the GelA-Tr FPR experiments did not permit a
distinction between normal and anomalous diffusion. The
GelA-Tr recovery curves (Fig. 5 b, curve C) based on
normal diffusion were fit to the data with no obvious pattern
of deviation as was observed for the GelA. An average
diffusion coefficient of 2.1  1.0  109 cm2 s1 and
mobile fraction of 0.12  0.02 were obtained.
Data analysis using either anomalous (GelA) or regular
(GelA-Tr) diffusion showed that only a fraction of the
enzyme is mobile at any given time. The size of the mobile
fraction decreased with increasing incubation time. If sam-
ples were bound to gelatin (see Materials and Methods) for
an hour before analysis, the mobile fraction fell to 0.10 in
the case of GelA and no detectable recovery was observed
for GelA-Tr. Thus, it appears that after a period of mobility
on the gelatin layer the ligand becomes fixed, perhaps
reflecting the essentially irreversible nature of binding to M
sites.
Finally, to confirm that the signal recovery in GelA FPR
experiments is due to a diffusion process, we have com-
pared the data collected with 16 and 40 microscope
objectives (Feder et al., 1996). Taking account of the 2.5-
fold difference in the size of the illuminated spot (w in Eqs.
3), we obtained nearly equal values of the diffusion coeffi-
cient (3.2 0.3 109 cm2 s1 and 2.1 0.5 109 cm2
s1), demonstrating that the kinetic process responsible for
fluorescence recovery had the spatial characteristics of dif-
fusion of the enzyme on gelatin substrate. Hence, results of
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FIGURE 5 Fluorescence photobleaching recovery from gelatin-ad-
sorbed fluorescently labeled GelA and GelA-Tr. Fluorescently labeled
enzymes GelA (1 M) or GelA-Tr (3 M) were prepared and applied to
glass coverslips. Fluorescence was excited with the attenuated beam (104
attenuation ratio) from an argon-ion laser (488 nm) and was observed with
a 40 microscope objective. Fluorescence was monitored for 20 s before
and 180 s after a 200-ms bleaching pulse (0.7 attenuation ratio). (a) The
complete record of an FPR experiment expressed as PMT response in
counts is plotted versus the time after the start of the experiment. The
record for GelA is displaced forward by 5 s for clarity. (b) Normalized
fluorescence recovery, Eq 3.2. (A) Fit of Eq 3.2 to the wild-type recovery
data; (B) Fit of Eq. 3.2 to the wild-type recovery data corrected for
anomalous diffusion.
Surface Diffusion of Gelatinase A 2375
Biophysical Journal 81(4) 2370–2377
FPR experiments confirm the hypothesis that GelA is ca-
pable of an anomalous lateral diffusion on gelatin and that
the C-terminal domain facilitates this process. Moreover,
the fractal-like nature of the gelatin-binding kinetics could
be a direct consequence of the fractal-like anomalous dif-
fusion process.
It is important to note that our results do not necessarily
imply that sets of distinct S and M binding sites occur on the
ECM substrate in vivo.
The existence of such distinction between the S and M
sites may due entirely to properties of the glass-adsorbed
gelatin layer. Gelatin, a polyampholyte with an isoelectric
pH of 4.9 adsorbs to the glass surface with a relatively flat
conformation at low pH. As the pH increases, the attractive
interaction between glass and gelatin decreases and the
gelatin extends away from the surface causing the layer to
swell (Braithwaite et al., 1999). Among other factors the
swelling might contribute to a restriction of accessibility of
some binding sites. Thus, the S sites are defined as a small
subset of binding sites on glass-adsorbed gelatin to which
the binding of the truncated mutant is restricted. Moreover,
the competition experiments show that the S sites impose a
bottleneck effect on the gelatin binding of GelA in this
experimental system.
The mechanism of GelA diffusion on its substrate is not
clear. The FN-like domain is the prime determinant of the
enzyme-gelatin interaction. Lateral diffusion requires a
transient interruption of the interaction between gelatin and
the FN-like domain. The role of the GelA-CTD could be to
promote such a transient effect by interacting directly with
the FN-like domain. Supporting this hypothesis are obser-
vations that the GelA-CTD can interact with GelA-Tr in
solution (Collier and Goldberg, unpublished results) and
more specifically with the third repeat of the FN-like do-
main as revealed by the crystal structure of GelA (Mor-
gunova et al., 1999). In addition, although the recombinant
GelA-CTD does not bind to gelatin appreciably, our data do
not exclude the possibility of their weak interaction, thus
aiding the displacement of the enzyme to nearby binding
sites in a stepwise fashion. The repetitive structure of the
collagens and gelatin may serve as an ideal substrate for
such a process.
What are the implications of these results to the processes
of tissue remodeling catalyzed by metalloproteases? Lateral
surface diffusion could be a widespread mechanism in the
metabolism of ECM where small molecules secreted by
resident cells are required to interact at specific sites within
large protein assemblies. This circumstance provides an
ideal environment in which diffusion at reduced dimension-
ality produces association rates beyond those that can be
supported by simple diffusion in three dimensions. Thus,
the rules of fractal kinetics and surface diffusion may pro-
vide a more appropriate view on these interactions com-
pared with the rules of solution biochemistry.
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